CellVoyant Technologies Ltd
Adel Benamara is a PhD in Computer Vision and the Machine Learning Engineering Lead at CellVoyant, dedicated to advancing innovative AI technologies tailored specifically for cell therapy and developmental biology research.
Adel leads the development of FateView™, a pioneering SaaS platform leveraging artificial intelligence and advanced computer vision to non-invasively analyze live-cell imaging and predict cell fate dynamics in real-time. FateView™ significantly enhances cell therapy efficiency by providing continuous, single-cell resolution insights, enabling precise optimization of differentiation protocols.
With over 10 years of experience in industrial manufacturing and IoT applications at Fives Group, Adel previously served as Senior Computer Vision Engineer and Team Lead at Fives CortX, where he developed advanced machine vision systems for predictive maintenance and quality control. His expertise bridges complex computational analytics with practical biological and industrial applications.
FATEVIEW™: AI-POWERED, NON-DESTRUCTIVE ‘LIVE’ CELL ANALYTICS AND CELL FATE FORECASTING
Wednesday, June 11, 2025
4:20 PM – 4:35 PM HK Time
FATEVIEW™: AI-POWERED, NON-DESTRUCTIVE ‘LIVE’ CELL ANALYTICS AND CELL FATE FORECASTING
Thursday, June 12, 2025
5:20 PM – 5:35 PM HK Time